Yorktown Management & Research Company’s Bio-Techne TECH Stock Holding History

Yorktown Management & Research Company’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,600	Closed	-$211K	–	234
2025 Q1	$211K	Hold	3,600	–	–	0.23%	199
2024 Q4	$259K	Hold	3,600	–	–	0.25%	189
2024 Q3	$288K	Hold	3,600	–	–	0.29%	175
2024 Q2	$258K	Hold	3,600	–	–	0.28%	180
2024 Q1	$253K	Buy	+3,600	New	+$258K	0.24%	204
2023 Q3	–	Sell	-4,800	Closed	-$392K	–	233
2023 Q2	$392K	Hold	4,800	–	–	0.42%	104
2023 Q1	$356K	Hold	4,800	–	–	0.38%	105
2022 Q4	$398K	Hold	4,800	–	–	0.49%	85
2022 Q3	$341K	Hold	4,800	–	–	0.44%	88
2022 Q2	$416K	Hold	4,800	–	–	0.54%	73
2022 Q1	$520K	Hold	4,800	–	–	0.44%	90
2021 Q4	$621K	Hold	4,800	–	–	0.42%	80
2021 Q3	$581K	Hold	4,800	–	–	0.44%	69
2021 Q2	$540K	Hold	4,800	–	–	0.42%	75
2021 Q1	$458K	Hold	4,800	–	–	0.38%	87
2020 Q4	$381K	Hold	4,800	–	–	0.34%	144
2020 Q3	$297K	Hold	4,800	–	–	0.28%	195
2020 Q2	$317K	Buy	+4,800	New	+$287K	0.28%	158

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Yorktown Management & Research Company's TECH Position: Q2 2025 in Review

Yorktown Management & Research Company sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 3,600 shares — an estimated $211K sold.

Yorktown Management & Research Company first reported a position in TECH in Q2 2020 and held it in 18 quarters. The position peaked at $621K in Q4 2021. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Yorktown Management & Research Company reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Yorktown Management & Research Company sold 3,600 Bio-Techne shares in Q2 2025, an estimated $211K.
Yorktown Management & Research Company first reported a position in Bio-Techne in Q2 2020 and held it in 18 quarters.
Yorktown Management & Research Company's Bio-Techne position peaked at $621K in Q4 2021.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Yorktown Management & Research Company's 13F filing for Q2 2025, filed 4 Aug 2025.